Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Scientific Reports Année : 2019

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

Résumé

The prognosis of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains unsatisfactory and, despite major advances in genomic studies, the biological mechanisms underlying chemoresistance are still poorly understood. We conducted for the first time a large-scale differential multi-omics investigation on DLBCL patient's samples in order to identify new biomarkers that could early identify patients at risk of R/R disease and to identify new targets that could determine chemorefractoriness. We compared a well-characterized cohort of R/R versus chemosensitive DLBCL patients by combining label-free quantitative proteomics and targeted RNA sequencing performed on the same tissues samples. The cross-section of both data levels allowed extracting a sub-list of 22 transcripts/proteins pairs whose expression levels significantly differed between the two groups of patients. In particular, we identified significant targets related to tumor metabolism (Hexokinase 3), microenvironment (IDO1, CXCL13), cancer cells proliferation, migration and invasion (S100 proteins) or BCR signaling pathway (CD79B). Overall, this study revealed several extremely promising biomarker candidates related to DLBCL chemorefractoriness and highlighted some new potential therapeutic drug targets. The complete datasets have been made publically available and should constitute a valuable resource for the future research.

Domaines

Chimie
Fichier principal
Vignette du fichier
Fornecker_2019.pdf (577.21 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02275054 , version 1 (08-10-2020)

Identifiants

Citer

Luc-Matthieu Fornecker, Leslie Muller, Frédéric Bertrand, Nicodème Paul, Angelique Pichot, et al.. Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma. Scientific Reports, 2019, 9 (1), ⟨10.1038/s41598-018-37273-4⟩. ⟨hal-02275054⟩
61 Consultations
58 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More